These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23832923)

  • 61. Drug safety labeling for doctors.
    Hecht A
    FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Generic prescription should be evaluated as new way of prescription in Denmark].
    Hellebek A; Søndergaaard J; Thirstrup S; Sales Y
    Ugeskr Laeger; 2012 Aug; 174(35):1974. PubMed ID: 22929572
    [No Abstract]   [Full Text] [Related]  

  • 63. Descriptive analysis of primary package labels from commercially available prescription solid oral dosage form drugs.
    Chermak TE; Lambert BL
    J Am Pharm Assoc (2003); 2009; 49(3):399-406. PubMed ID: 19443320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Product information for generic drugs: old, unloved and sometimes unsafe.
    Doogue MP; Thynne TR
    Intern Med J; 2013 Dec; 43(12):1346-8. PubMed ID: 24330367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The FDA announces new prescription drug information format.
    FDA Consum; 2006; 40(2):25-7. PubMed ID: 16671197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Descriptive labeling may reduce prescription errors.
    Falbe WJ; Geater RE
    Am J Hosp Pharm; 1989 Dec; 46(12):2459-60. PubMed ID: 2603873
    [No Abstract]   [Full Text] [Related]  

  • 68. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 69. OTC labeling reform.
    J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
    [No Abstract]   [Full Text] [Related]  

  • 70. Tall Man lettering and potential prescription errors: a time series analysis of 42 children's hospitals in the USA over 9 years.
    Zhong W; Feinstein JA; Patel NS; Dai D; Feudtner C
    BMJ Qual Saf; 2016 Apr; 25(4):233-40. PubMed ID: 26534995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The outpatient prescription label as a source of medication errors.
    Hermann F
    Am J Hosp Pharm; 1973 Feb; 30(2):155-9. PubMed ID: 4690470
    [No Abstract]   [Full Text] [Related]  

  • 72. Adherence to black box warnings for prescription medications in outpatients.
    Lasser KE; Seger DL; Yu DT; Karson AS; Fiskio JM; Seger AC; Shah NR; Gandhi TK; Rothschild JM; Bates DW
    Arch Intern Med; 2006 Feb; 166(3):338-44. PubMed ID: 16476875
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Homeopathic drugs: look-alike meds.
    Consum Rep; 2008 Jun; 73(6):45. PubMed ID: 18979665
    [No Abstract]   [Full Text] [Related]  

  • 74. Capsule Commentary on Wolf et al., A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.
    Smieliauskas F
    J Gen Intern Med; 2016 Dec; 31(12):1507. PubMed ID: 27599487
    [No Abstract]   [Full Text] [Related]  

  • 75. Miss-'n-mix and mimics. Batch DM 998.
    Baele PL
    Acta Anaesthesiol Belg; 2003; 54(2):149-50. PubMed ID: 12872431
    [No Abstract]   [Full Text] [Related]  

  • 76. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(92):27591-3. PubMed ID: 22606729
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A tall man lettering project to enhance medication safety.
    U D; Cohen MR
    Farm Hosp; 2011; 35(5):223-4. PubMed ID: 21813310
    [No Abstract]   [Full Text] [Related]  

  • 78. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A; Allan N; Wills B; Kang C; Leikin JB
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public".
    Steinman MA
    Arch Intern Med; 2011 Sep; 171(16):1468-9. PubMed ID: 21911630
    [No Abstract]   [Full Text] [Related]  

  • 80. History in the making: the evolution of consumer product information (CPI).
    Shenfield GM; Tasker JL
    Med J Aust; 1997 Apr; 166(8):425-8. PubMed ID: 9140350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.